On March 31, 2025, Talphera Inc. entered into a securities purchase agreement for a private placement, raising approximately $4.9 million by selling shares and pre-funded warrants, with additional closings contingent on patient enrollment in a study. The first closing occurred on April 2, 2025, with similar terms expected for the second and third closings based on specific conditions.